Charles River Laboratories
CRL
Charles River Laboratories (CRL) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $4.53 B
According to Charles River Laboratories 's latest financial reports the company's total liabilities are $4.53 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Charles River Laboratories - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $4.53 B | -0.94% |
| 2022-12-31 | $4.57 B | 3.32% |
| 2021-12-31 | $4.43 B | 32.42% |
| 2020-12-31 | $3.34 B | 10.6% |
| 2019-12-31 | $3.02 B | 20.21% |
| 2018-12-31 | $2.51 B | 34.93% |
| 2017-12-31 | $1.86 B | 0.42% |
| 2016-12-31 | $1.85 B | 42.6% |
| 2015-12-31 | $1.30 B | 11.72% |
| 2014-12-31 | $1.16 B | 20.47% |
| 2013-12-31 | $0.96 B | -1.53% |
| 2012-12-31 | $0.98 B | -4.64% |
| 2011-12-31 | $1.03 B | -1.31% |
| 2010-12-31 | $1.04 B | 25.82% |
| 2009-12-31 | $0.83 B | -13.56% |
| 2008-12-31 | $0.96 B | 2.01% |
| 2007-12-31 | $0.94 B | -1.21% |
| 2006-12-31 | $0.95 B | 35.87% |
| 2005-12-31 | $0.70 B | -38.71% |
| 2004-12-31 | $1.14 B | 252.43% |
| 2003-12-31 | $0.32 B | -0.2% |
| 2002-12-31 | $0.32 B | 21.03% |
| 2001-12-31 | $0.26 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $51.88 B | 1,043.83% | 🇺🇸 USA |
 SCYNEXIS SCYX | $56.55 M | -98.75% | 🇺🇸 USA |
 Repligen
RGEN | $0.85 B | -81.19% | 🇺🇸 USA |